Artal Group as of June 30, 2017
Portfolio Holdings for Artal Group
Artal Group holds 90 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blue Buffalo Pet Prods | 34.9 | $2.0B | 88M | 22.81 | |
| Weight Watchers International | 17.2 | $984M | 29M | 33.42 | |
| Lexicon Pharmaceuticals (LXRX) | 16.5 | $946M | 58M | 16.45 | |
| Goldman Sachs (GS) | 6.0 | $344M | 1.6M | 221.90 | |
| Bank of America Corporation (BAC) | 3.6 | $205M | 8.5M | 24.26 | |
| MetLife (MET) | 2.5 | $143M | 2.6M | 54.94 | |
| Gilead Sciences (GILD) | 1.6 | $89M | 1.3M | 70.78 | |
| Incyte Corporation (INCY) | 1.3 | $76M | 600k | 125.91 | |
| Microsoft Corporation (MSFT) | 1.2 | $69M | 1.0M | 68.93 | |
| Bristol Myers Squibb (BMY) | 1.0 | $56M | 1.0M | 55.72 | |
| Nektar Therapeutics (NKTR) | 0.8 | $47M | 2.4M | 19.55 | |
| Agios Pharmaceuticals (AGIO) | 0.7 | $41M | 800k | 51.45 | |
| Tesaro | 0.7 | $40M | 285k | 139.86 | |
| BioMarin Pharmaceutical (BMRN) | 0.6 | $36M | 400k | 90.82 | |
| Wells Fargo & Company (WFC) | 0.6 | $36M | 650k | 55.41 | |
| Abbvie (ABBV) | 0.6 | $36M | 500k | 72.51 | |
| Citigroup (C) | 0.6 | $33M | 500k | 66.88 | |
| Bluebird Bio (BLUE) | 0.6 | $32M | 300k | 105.05 | |
| International Business Machines (IBM) | 0.5 | $31M | 200k | 153.83 | |
| Neurocrine Biosciences (NBIX) | 0.4 | $25M | 550k | 46.00 | |
| Morgan Stanley (MS) | 0.4 | $22M | 500k | 44.56 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $22M | 275k | 79.76 | |
| Medicines Company | 0.4 | $21M | 550k | 38.01 | |
| Acceleron Pharma | 0.4 | $21M | 700k | 30.39 | |
| Amicus Therapeutics (FOLD) | 0.3 | $19M | 1.9M | 10.07 | |
| Beigene (BGNE) | 0.3 | $18M | 400k | 45.00 | |
| Radius Health | 0.3 | $16M | 350k | 45.23 | |
| Alexion Pharmaceuticals | 0.3 | $15M | 121k | 121.67 | |
| Teradyne (TER) | 0.3 | $15M | 500k | 30.03 | |
| Horizon Pharma | 0.3 | $15M | 1.3M | 11.87 | |
| Array BioPharma | 0.2 | $12M | 1.5M | 8.37 | |
| Ironwood Pharmaceuticals (IRWD) | 0.2 | $12M | 617k | 18.88 | |
| Avexis | 0.2 | $12M | 140k | 82.16 | |
| Kite Pharma | 0.2 | $10M | 100k | 103.67 | |
| Global Blood Therapeutics In | 0.2 | $9.6M | 350k | 27.35 | |
| Athene Holding Ltd Cl A | 0.2 | $9.9M | 200k | 49.61 | |
| Seattle Genetics | 0.2 | $9.1M | 175k | 51.75 | |
| Ignyta | 0.2 | $9.3M | 900k | 10.35 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $8.4M | 250k | 33.71 | |
| Agenus (AGEN) | 0.1 | $7.8M | 2.0M | 3.91 | |
| Sage Therapeutics (SAGE) | 0.1 | $7.2M | 90k | 79.64 | |
| Juno Therapeutics | 0.1 | $7.5M | 250k | 29.89 | |
| Atara Biotherapeutics (ATRA) | 0.1 | $7.0M | 500k | 14.00 | |
| Seres Therapeutics (MCRB) | 0.1 | $6.8M | 600k | 11.30 | |
| Ionis Pharmaceuticals (IONS) | 0.1 | $6.9M | 135k | 50.87 | |
| Elf Beauty (ELF) | 0.1 | $6.8M | 250k | 27.21 | |
| Zto Express Cayman (ZTO) | 0.1 | $7.0M | 500k | 13.96 | |
| Versartis | 0.1 | $6.1M | 350k | 17.45 | |
| Accelr8 Technology | 0.1 | $5.5M | 200k | 27.35 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $6.0M | 250k | 23.93 | |
| Tg Therapeutics (TGTX) | 0.1 | $5.0M | 500k | 10.05 | |
| Macrogenics (MGNX) | 0.1 | $5.3M | 300k | 17.51 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $4.7M | 850k | 5.56 | |
| Chemocentryx | 0.1 | $4.7M | 500k | 9.36 | |
| Five Prime Therapeutics | 0.1 | $4.5M | 150k | 30.11 | |
| Achaogen | 0.1 | $4.3M | 200k | 21.73 | |
| Ac Immune Sa (ACIU) | 0.1 | $4.4M | 500k | 8.80 | |
| BioTime | 0.1 | $4.0M | 1.3M | 3.15 | |
| Axovant Sciences | 0.1 | $4.1M | 175k | 23.19 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $4.2M | 300k | 13.97 | |
| Intellia Therapeutics (NTLA) | 0.1 | $4.0M | 250k | 16.00 | |
| Zafgen | 0.1 | $3.5M | 1.0M | 3.51 | |
| Alder Biopharmaceuticals | 0.1 | $3.4M | 300k | 11.45 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $3.2M | 160k | 19.75 | |
| Jounce Therapeutics | 0.1 | $3.5M | 250k | 14.03 | |
| Freeport-McMoRan Copper & Gold (FCX) | 0.1 | $3.0M | 250k | 12.01 | |
| Chimerix (CMRX) | 0.1 | $2.7M | 500k | 5.45 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $3.1M | 50k | 62.12 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $2.6M | 500k | 5.20 | |
| Calithera Biosciences | 0.1 | $3.0M | 200k | 14.85 | |
| Spark Therapeutics | 0.1 | $3.0M | 50k | 59.74 | |
| Cellectis S A (CLLS) | 0.1 | $2.6M | 100k | 25.82 | |
| Clovis Oncology | 0.0 | $2.3M | 25k | 93.64 | |
| D Stemline Therapeutics | 0.0 | $2.3M | 250k | 9.20 | |
| Glycomimetics (GLYC) | 0.0 | $2.3M | 203k | 11.16 | |
| Vital Therapies | 0.0 | $2.5M | 875k | 2.90 | |
| Minerva Neurosciences | 0.0 | $2.2M | 251k | 8.85 | |
| Aimmune Therapeutics | 0.0 | $2.1M | 100k | 20.56 | |
| Noveliontherapeuti.. | 0.0 | $2.4M | 256k | 9.23 | |
| Celldex Therapeutics | 0.0 | $1.7M | 675k | 2.47 | |
| Corbus Pharmaceuticals Hldgs | 0.0 | $1.6M | 250k | 6.30 | |
| Nantkwest | 0.0 | $1.7M | 225k | 7.59 | |
| Verastem | 0.0 | $1.1M | 500k | 2.18 | |
| Aduro Biotech | 0.0 | $1.1M | 100k | 11.40 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $1.3M | 300k | 4.49 | |
| Novavax | 0.0 | $575k | 500k | 1.15 | |
| Neuroderm Ltd F | 0.0 | $748k | 25k | 29.92 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $473k | 150k | 3.15 | |
| Dimension Therapeutics | 0.0 | $340k | 235k | 1.45 | |
| Oncocyte | 0.0 | $780k | 150k | 5.20 |
